Dr. John Hamer is associated with DCVC, an investment firm. He wrote about a partnership between AbCellera and Novartis to find new disease treatments.
What John can write
DCVC writes $10M to $30M+ checks, larger than 97% of firms in the atlas.
Bars: how many firms report each check band. Highlighted: DCVC.Career
- Purdue University · Full Professor
- Paradigm Genetics · Visiting Scientist
- Paradigm Genetics · Chief Science Officer
- Paradigm Genetics · President and CEO
- Burrill & Company · Managing Director
- Monsanto · VP
- Monsanto Growth Ventures · Managing Director
- DCVC Bio · Managing Partner
- DCVC · Managing Partner, DCVC BioNow
Companies founded
Focus
Education
Also at DCVC
Partners like John
At firms with a similar stage, sector and check size.
Alert me when DCVC is active
One email when John's firm raises a fund, adds a partner or shows new activity.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQuestions
Who is John Hamer?
Dr. John Hamer is associated with DCVC, an investment firm. He wrote about a partnership between AbCellera and Novartis to find new disease treatments.
How much does John Hamer invest?
John Hamer invests through DCVC, which writes checks of $10M to $30M+ at seed, series a.
How do I pitch John Hamer?
Email [email protected], the firm's inbox for founders, and name John in the subject. A warm intro from a founder DCVC backed works better.
What did John Hamer do before DCVC?
Full Professor at Purdue University; Visiting Scientist at Paradigm Genetics; Chief Science Officer at Paradigm Genetics; President and CEO at Paradigm Genetics; Managing Director at Burrill & Company; VP at Monsanto; Managing Director at Monsanto Growth Ventures; Managing Partner at DCVC Bio.
Last updated 2026-10-15. Is this you? Ask for a correction.